Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Frequently asked questions
What sector does Aesthetic Medical International Holdings Group Limited (AIH) operate in?
Aesthetic Medical International Holdings Group Limited belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Aesthetic Medical International Holdings Group Limited (AIH) Earnings Per Share (EPS)?
The trailing EPS is -$0.12.
What is Aesthetic Medical International Holdings Group Limited (AIH) EBITDA?
Aesthetic Medical International Holdings Group Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -9.86 million.
Does Aesthetic Medical International Holdings Group Limited (AIH) pay dividends?
No. Aesthetic Medical International Holdings Group Limited does not pay a dividend.
When is Aesthetic Medical International Holdings Group Limited (AIH) next earnings report?
Aesthetic Medical International Holdings Group Limited is expected to release its next earnings report on June 30, 2024.
